Pharmacokinetic Interaction between Indinavir and Darunavir with Low-Dose Ritonavir in Healthy Volunteers
Author(s) -
Vanitha Sekar,
Éric Lefebvre,
Tine De Marez,
Martine De Pauw,
Els De Paepe,
Tony Vangeneugden,
Richard M. W. Hoetelmans
Publication year - 2010
Publication title -
intervirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.641
H-Index - 61
eISSN - 1423-0100
pISSN - 0300-5526
DOI - 10.1159/000289341
Subject(s) - darunavir , pharmacokinetics , ritonavir , indinavir , adverse effect , tolerability , medicine , chemistry , pharmacology , human immunodeficiency virus (hiv) , viral load , antiretroviral therapy , immunology
To investigate the potential for a pharmacokinetic interaction between darunavir (DRV, TMC114, Prezista), indinavir (IDV, Crixivan) and low-dose ritonavir (RTV, Norvir).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom